'Boosting pancreatic cancer chemotherapy by disrupting nerve–cancer crosstalk' - an Acta Materia Medica article on #ScienceOpen:
🔗 https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0092
🖇️ #CancerBiology #Pharmaceutics #Biochemistry #PancreaticCancer
Boosting pancreatic cancer chemotherapy by disrupting nerve–cancer crosstalk
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d1507291e119">A preclinical study has developed a precision nano-intervention strategy targeting tumor-associated nerves to destroy nerve-fueled tumor growth in pancreatic cancer. In this strategy, <i>Escherichia coli</i> Nissle 1917-derived outer membrane vesicles (OMVs) are decorated with nerve-binding peptide for targeted delivery of co-loaded tropomyosin receptor kinase (Trk) inhibitors to tumor-associated nerves, thus precisely inhibiting nerve activity through the neurotrophin/Trk signaling pathway. Furthermore, the OMVs trigger M2-M1 switching, thus accelerating nerve injury. This nano-intervention strategy significantly enhances chemotherapy efficacy in pancreatic cancer. </p>



